Observational studyJournal of autoimmunity2020

Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab.

Austin R Morrison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.